Aberrant expression of perilipins and 11-β-HSD-1 as molecular signatures of metabolic syndrome X in South East Asians

Journal of Association of Physicians of India

Volumn 54, Issue AUG., 2006, Pages 637-649

  Das, U N ^a  

^a UND LIFE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; PERILIPIN; PHOSPHOPROTEIN;

ASIAN; HUMAN; METABOLIC SYNDROME X; METABOLISM; REVIEW;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ASIAN CONTINENTAL ANCESTRY GROUP; HUMANS; METABOLIC SYNDROME X; PHOSPHOPROTEINS;

EID: 33747138332     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. McKeigue P, Sevak L. Coronary heart disease in South Asian Communities. London: Health Education Authority, 1994.
2. Hansen BC, Jen K-L, Schwartz J. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int J Obes 1988;12:391-401.
3. Das UN. Exercise and inflammation. Eur Heart J in press.
4. Das UN. Anti-inflammatory nature of exercise. Nutrition 2004;20:323-26.
5. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861-67.
6. Bjorntorp P. Adipose tissue distribution and function. Int J Obes 1991;15(Suppl 2):67-81.
7. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-62.
8. Pederson O, Hjollund E, Lindskov HO. Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 1982;243:E158-67.
9. Rebuffe-Scrive M, Enk L, Crona N, Lonnroth P, Abrahamsson L, Smith U, Bjorntorp P. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest 1985;75:1973-76.
10. Orel M, Lichnovska R, Gwozdziewiczova S, Zlamalova N, Klementa I, Merkunova A, Hrebicek J. Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiol Res 2004;53:501-5.
11. Das UN. Sex differences in the number of adipose cells. XX vs. XY 2003;1:132-33.
12. Montague CI, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998;47:1384-91.
13. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997;99:2416-22.
14. Ramos EJB, Xu Y, Romanova I, Middleton F, Chen C, Quinn R, Inui A, Das UN, Meguid MM. Is obesity an inflammatory disease? Surgery 2003;134:329-35.
15. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-16.
16. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999;48:1113-19.
17. Perseghin G, Scifo P, DeCobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-06.
18. Forouchi NG, Jenkinson G, Thomas EL, Mullick S, Mierisova S, Bhonsle U, McKeigue PM, Bell JD. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 1999;42:932-35.
19. Sinha S, Rathi M, Misra A, Kumar V, Kumar M, Jagannathan NR, Pandey RM, Dwivedi M, Luthra K. Subclinical inflammation and soleus muscle intramyocellular lipids in healthy Asian Indian males. Clin Endocrinol (Oxf) 2005;63:350-55.
20. Frost GS, Goff LM, Hamilton G, Thomas EL, Dhillo WS, Dornhorst A, Bell JD. Carbohydrate-induced manipulation of insulin sensitivity independently of intramyocellular lipids. Br J Nutr 2003;89:365-75.
21. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, Shulman G, Caprio S. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003;88:2014-8.
22. Poynten AM, Gan SK, Kriketos AD, O'Sullivan A, Kelly JJ, Ellis BA, Chisholm DJ, Campbell LV. Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content. Metabolism 2003;52:699-704.
23. Van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA. Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 2004;287:E558-65.
24. Kelley DE. Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance. Curr Diab Rep 2004;4:165-68.
25. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, Claussen C, Jacob S, Schick F, Haring HU, Stumvoll M. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1785-91.
26. Pruchnic R, Katsiaras A, He J, Kelley DE, Winters C, Goodpaster BH. Exercise training increases intramyocellular lipid and oxidative capacity in older adults. Am J Physiol Endocrinol Metab 2004;287:E857-62.
27. He J, Goodpaster BH, Kelley DE. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obes Res 2004;12:761769.
28. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhausl W, Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006;55:136-40.
29. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie JE, Londos C. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 1991;266:11341-346.
30. Greenberg AS, Egan JJ, Wek SA, Moos MC Jr, Londos C, Kimmel AR. Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes. Proc Natl Acad Sci USA 1993;90:12035-39.
31. Brasaemle DL, Rubin B, Harten IA, Gruia-Gray J, Kimmel AR, Londos C. Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 2000;275:38486-93.
32. Clifford GM, Londos C, Kraemer FB, Vernon RG, Yeaman SJ. Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J Biol Chem 2000;275:5011-15.
33. He J, Goodpaster BH, Kelley DE. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obes Res 2004;12:761-69.
34. Hesselink MKC, Mensink M, Schrauwen P. Intramyocellular lipids and insulin sensitivity: Does size really matter? Obes Res 2004;12:741-42.
35. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng C-X, Li C, Kimmel AR, Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to dit-induced obesity. Proc Natl Acad Sci USA 2001;98:6494-99.
36. Saha PK, Kojima H, Martinez-Botas J, Sunehag AL, Chan L. Metabolic adaptations in th absence of perilipin. J Biol Chem 2004;279:35150-158.
37. Castro-Chavez F, Yechoor VK, Saha PK, Martinez-Botas J, Wooten EC, Sharma S, O'Connell P, Taegtmeyer H, Chan L. Coordinated upregulation of oxidative pathways and downregulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice. A microarray gene expression profile. Diabetes 2003;52:2666-74.
38. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, Gorenstein D, Chen KH, Chan I. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 2000;26:474-79.
39. Miura S, Gan J-W, Brzostowski J, Parisi MJ, Schultz CJ, Londos C, Oliver B, Kimmel AR. Functional conservation for lipid storage droplet association among perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J Biol Chem 2002;277:32253-57.
40. Wang Y, Sullivan S, Trujillo M, Lee M-J, Schneider SH, Brolin RE, Kang YH, Werber Y, Greenberg AS, Fried SK. Perilipin expression in human adipose tissues: Effects of severe obesity, gender, and depot. Obes Res 2003;11:930-36.
41. Large V, Reynisdottir S, Langin D, et al. Decreased expression and function of adipocyte hormone-sensitive lipiase in subcutaneous fat cells of obese subjects. J Lipid Res 1999;40:2059-66.
42. Tansey JJ, Huml AM, Vogt R, et al. Functional studies on native and mutated forms of perilipins: a role in protein kinase A-mediated lipolysis of triacylglycerol in CHO cells. J Biol Chem 2003;278:8401-06.
43. Lofgren P, Hoffstedt J, Ryden M, et al. Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity before and after long-term weight reduction. J Clin Endocrinol Metab 2002;87:764-71.
44. Kern PA, Di Gregorio G, Lu T, Rassouli N, Ranganathan G. Perilipin expression in human adipose tissue is elevated with obesity. J Clin Endocrinol Metab 2004;89:1352-58.
45. Servetnick DA, Brasaemle DI, Gruia-Gray J, Kimmel AR, Wolff J, Londos C. Perilipins are associated with cholesteryl ester droplets in steroidogenic adrenal cortical and Leydig cells. J Biol Chem 1995;270:16970-973.
46. Lu X, Gruia-Gray J, Copeland NG, Gilbert DJ, Jenkins NA, Londos C, Kimmel AR. The murine perilipin gene: the lipid droplet-associated perilipins derive from tissue-specific, mRNA splice variants and define a gene family of ancient origin. Mamm Genome 2001;12:741-49.
47. Sztalryd C, Xu G, Dorward H, Tansey JT, Contreras JA, Kimmel AR, Londos C. Perilipin A is essential for the translocation of hormone-sensitive lipiase during lipoltic activation. J Cell Biol 2003;161:1093-1103.
48. Spiegelman BM, Flier JS. Adipogenesis and obesity:rounding out the big picture. Cell 1996;87:377-89.
49. Fikuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30.
50. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953-66.
51. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002;18:430-32.
52. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue in obese Zucker rats. J Clin Invest 1998;101:1354-61.
53. Kubota N, Terauchi Y, Miki H, et al. PPAR ≥ mediates highfat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-609.
54. Souza SC, Moitoso de Vargas L, Yamamoto MT, Lien P, Franciosa MD, Moss LG, Greenberg AS. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor ± to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 1998;273:24665-669.
55. Arimura N, Horiba T, Imagawa M, Shimizu M, Sato R. The peroxisome proliferator-activated receptor ≥ regulates expression of the perilipin gene in adipocytes. J Biol Chem 2004;279:10070-76.
56. Nagai S, Shimizu C, Umetsu M, Taniguchi S, Endo M, Miyoshi H, Yoshika N, Kubo M, Koike T. Identification of a functional peroxisome proliferator- activated receptor responsive element within the murine perilipin gene. Endocrinology 2004;145:2346-56.
57. Shimizu M, Takeshita A, Tsukamoto T, Gonzalez FJ, Osumi T. Tissue-selective, bidirectional regulation of PEX1 1± and perilipin genes through a common peroxisome proliferator response elment. Mol Cell Biol 2004;24:1313-23.
58. Rousseaux C, Lefebyre B, Dubuquoy L, Lefebyre P, Rpmano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med 2005;201:1205-15.
59. Fujii H. Anti-inflammatory action of PPARs. Nippon Rinsho 2005;63:609-15.
60. Dvorak AM, Morgan E, Schleimer RP, Ryeom SW, Lichetenstein LM, Weller PF. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem 1992;40:759-69.
61. Yu W, Bozza PT, Tzizik DM, Gray JP, Cassara J, Dvoak AM, Weller PF. Co-compartmentalization of MAP kinases and cytosolic phospholipiase A2 at cytoplasmic arachidonate-rich lipid bodies. Am J Pathol 1998;152:759-69.
62. Weller PF, Dvorak AM. Lipid bodies: intracellular sites for eicosanoid formation. J Allergy Clin Immunol 1994;94:1151-6.
63. Meadows JW, Pitzer B, Brockman DE, Myatt L. Expression and localizatin of adipophilin and perilipin in human fetal membranes: association with lipid bodies and ezymes involved in prostaglandin synthesis. J Endocrinol Metab 2005;90:2344-50.
64. Beckman M.Great balls of fat. Science 2006;311:1232-34.
65. Mohan IK, Das UN. Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997;25:55-57.
66. Das UN. Metabolic syndrome X is common in South Asians: But, why and how? Nutrition 2002;18:774776.
67. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002;227:989-97.
68. Das UN. Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: Further discussion and some suggestions. Nutrition 2003;19:560-62.
69. Das UN. Metabolic syndrome X: an inflammatory condition? Current Hypertension Reports 2004;6:66-73.
70. Das UN. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 2005;21:762-73.
71. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-25.
72. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70.
73. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999;140:3188-96.
74. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 2002;87:5630-35.
75. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier LJ, Permana PA. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 2004;47:1088-95.
76. Robitaille J, Brouillette C, Houde A, Despres JP, Tchernof A, Vohl MC. Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome. Obes Res 2004;12:1570-75.
77. Sandeep TC, Andrew R, Homer N, Andrews RC, Smith K, Walker BR. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 2005;54:872-79.
78. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004;53:931-38.
79. Handoko K, Yang K, Strutt B, Khalil W, Killinger D. Insulin attenuates the stimulatory effects of tumor necrosis factor alpha on 11beta-hydroxysteroid dehydrogenase 1 in human adipose stromal cells. J Steroid Biochem Mol Biol 2000; 72: 163-8.
80. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001;142:1982-89.
81. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-94.
82. Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, Vidal-Puig A, Jones R, Considine RV. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 2005;13:662-69.
83. Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 2002;277:46226-32.
84. Davis KE, Moldes M, Farmer SR. The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. J Biol Chem 2004;279:42453-61.
85. Das UN. Is insulin an anti-inflammatory molecule? Nutrition 2001;17:409-13.
86. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002;45:924-30.
87. Wang Y, Sullivan S, Trujillo M, Lee M-J, Schneider SH, Brolin RE, Kang YH, Werber Y, Greenberg AS, Fried SK. Perilipin expression in human adipose tissues: Effects of severe obesity, gender, and depot. Obes Res 2003;11:930-36.
88. Wu C-C, Croxtall JD, Perretti M, Bryant CE, Thiemermann C, Flower RJ, Vane JR. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 1995;92:3473-7.
89. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002;22:7802-11.
90. Crafford LJ, Wilder RL, Ristimaki AP, Sano M, Remmers EF, Epps HR, Hla T. Cyclooxygenase-1 and -2 expression in rheumatoid arthritis synovial tissues. J Clin Invest 1994;93:109-1101.
91. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-47.
92. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
93. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the inducible synthesis. Proc Natl Acad Sci USA 1993;90:4475-79.
94. Kunicka JE, Talle MA, Denhardt GH, Brown M, Prince LA, Goldstein G. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol 1993;149:39-49.
95. Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 1994;93:1940-47.
96. 4 in bronchial epithelial cells. Eur Respir J 2003;22:35-42.
97. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149(4 Pt 1):953-59.
98. Ferrante JV, Ferrante A. Novel role of lipoxygenases in the inflammatory response: promotion of TNF mRNA decay by 15-hydroperoxyeicosatetraenoic acid in a monocytic cell line. J Immunol 2005;174:3169-72.
99. Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 2003;170:6266-72.
100. Wu SH, Lu C, Dong L, Zhou GP, He ZG, Chen ZQ. Lipoxin A4 inhibits TNF- alpha-induced production of interleukins and proliferation of rat mesangial cells. Kidney Int 2005;68:35-46.
101. 2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993;268:11290-295.
102. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000;85:2970-73.
103. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002;75:767-72.
104. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944-48.
105. Fan J, Frey RS, Rahman A, Malik AB. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-a-induced NF-kB activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002;277:3404-11.
106. Das UN. Insulin resistance and hyperinsulinemia: are they secondary to an alteration in the metabolism of essential fatty acids. Med Sci Res 1994;22:243-45.
107. Seeds MC, Jones DF, Chilton FH, Bass DA. Secretory and cytosolic phospholipase A2 are activated during TNF priming of human neutrophils. Biochim Biophys Acta 1998;1389:273-84.
108. Wu T, Ikezono T, Angus CW, Shelhamer JH. Tumor necrosis factor-alpha induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cells. Biochim Biophys Acta 1996;1310:175-84.
109. Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991;266:2647-51.
110. Dandona P, Mohanty P, Ghanim H, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001;86:355-62.
111. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155-60.